1. U.S. Food and Drug Administration. Food and Drug Administration Modernization Act of 1997: section 121. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDAMA/FullTextofFDAMAlaw/default.htm#SEC. 121. Published January 7, 1997. Accessed November 29, 2012.
2. U.S. Pharmacopeial Convention. USP 22–NF 17, Fludeoxyglucose F 18 Injection. Rockville, MD: U.S. Pharmacopeial Convention; 1990:579–580.
3. Food and Drug Administration. Guidance for industry: CGMP for phase 1 investigational drugs. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070273.pdf. Published July 2008. Accessed November 29, 2012.
4. Food and Drug Administration. Guidance for industry: analytical procedures and methods validation [draft]. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM122858.pdf. Published August 2000. Accessed November 29, 2012.
5. U.S. Pharmacopeial Convention. USP 32–NF 27, Validation of Compendial Procedures <1225>. Rockville, MD: U.S. Pharmacopeial Convention; 2009:1–33.